While WRN is commonly regarded as a tumor suppressor, its pharmacological inhibition was proposed to achieve synthetic‐lethal effects in neoplastic cells characterized by high replication stress [214, 215], which may render it effective also against MYC‐overexpressing cancer. This evidence concerns the gene WRN and cancer.